SCHEMBL5537229

SCHEMBL5537229

[CH2]c1ccnn1-c1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.40
HSP90AA1 P07900 1/20 0.39
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TYK2 P29597 1/20 0.38
JAK3 P52333 1/20 0.38
MGLL Q99685 1/20 0.37
PKM P14618 1/20 0.37
MAPK14 Q16539 3/20 0.36
MAPK11 Q15759 2/20 0.36
ADRB1 P08588 1/20 0.36
KCNN4 O15554 1/20 0.36
GAA P10253 1/20 0.35
BCHE P06276 1/20 0.34
P2RX7 Q99572 1/20 0.34
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
NOTUM Q6P988 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5537237 0.77 PKM (0.43) NR3C2HSP90AA1JAK2JAK1TYK2
SCHEMBL15554413 0.77 NR3C2 (0.40) NR3C2HSP90AA1JAK2JAK1TYK2
SCHEMBL14696532 0.77 HSP90AA1 (0.44) NR3C2HSP90AA1JAK2JAK1TYK2
SCHEMBL10992734 0.77 POLB (0.55) NR3C2HSP90AA1JAK2JAK1TYK2
Hydrochloric Acid SCHEMBL11473793 0.76 POLB (0.53) NR3C2HSP90AA1JAK2JAK1TYK2
SCHEMBL29452537 0.74 NR3C2 (0.53) NR3C2HSP90AA1JAK2JAK1TYK2
SCHEMBL28026330 0.72 MAPK14 (0.49) NR3C2MGLLPKMMAPK14MAPK11
SCHEMBL15428604 0.70 NR3C2 (0.50) NR3C2HSP90AA1JAK2JAK1TYK2
SCHEMBL20897191 0.70 HSP90AA1 (0.51) NR3C2HSP90AA1JAK2JAK1TYK2
SCHEMBL27610654 0.68 KCNN4 (0.51) KCNN4BCHEP2RX7TSHRNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102532162-B 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMA CO LTD 2015-05-27 CN disclosed
EP-2570418-A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-20 EP disclosed
EP-1555267-B1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES OTSUKA PHARMA CO LTD (JP) 2013-01-16 EP disclosed
CN-101255170-A 2,3-dihydroimidazo[2,1-b]oxazole compound OTSUKA PHARMA CO LTD (JP) 2008-09-03 CN disclosed
CN-101172981-A 2,3-dihydroimidazo[2,1-b]oxazole compound OTSUKA PHARMA CO LTD (JP) 2008-05-07 CN disclosed
CN-100366624-C 2, 3-dihydro-6-nitroimidazo [2,1-b ] * azole compounds OTSUKA PHARMA CO LTD (JP) 2008-02-06 CN disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-05-04 US disclosed
CN-1705670-A 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds OTSUKA PHARMA CO LTD (JP) 2005-12-07 CN disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles NR2C2, NR4A3, NR4A2 NR3C2 13/4885HSP90AA1 2426/4885JAK2 4213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.